Monthly Archives: March 2022

Randomized controlled trial limitations: a case study of vaccine efficacy in COVID-19 epidemiology

Randomized controlled trials (RCTs) are considered the “gold standard” in clinical medicine. Perhaps for this reason, health authorities all over the world have assumed the universal validity of RCTs and have not recognized that RCT results may not be valid … Continue reading

Posted in Economics | Leave a comment